S&P 500   3,120.46 (+0.77%)
DOW   28,004.89 (+0.80%)
QQQ   202.91 (+0.73%)
BABA   185.49 (+1.47%)
GE   11.52 (+2.04%)
T   39.50 (+1.41%)
ACB   2.73 (-17.02%)
F   8.95 (+1.82%)
PRI   130.62 (+0.32%)
BAC   32.93 (+0.70%)
DIS   144.67 (-1.69%)
S&P 500   3,120.46 (+0.77%)
DOW   28,004.89 (+0.80%)
QQQ   202.91 (+0.73%)
BABA   185.49 (+1.47%)
GE   11.52 (+2.04%)
T   39.50 (+1.41%)
ACB   2.73 (-17.02%)
F   8.95 (+1.82%)
PRI   130.62 (+0.32%)
BAC   32.93 (+0.70%)
DIS   144.67 (-1.69%)
S&P 500   3,120.46 (+0.77%)
DOW   28,004.89 (+0.80%)
QQQ   202.91 (+0.73%)
BABA   185.49 (+1.47%)
GE   11.52 (+2.04%)
T   39.50 (+1.41%)
ACB   2.73 (-17.02%)
F   8.95 (+1.82%)
PRI   130.62 (+0.32%)
BAC   32.93 (+0.70%)
DIS   144.67 (-1.69%)
S&P 500   3,120.46 (+0.77%)
DOW   28,004.89 (+0.80%)
QQQ   202.91 (+0.73%)
BABA   185.49 (+1.47%)
GE   11.52 (+2.04%)
T   39.50 (+1.41%)
ACB   2.73 (-17.02%)
F   8.95 (+1.82%)
PRI   130.62 (+0.32%)
BAC   32.93 (+0.70%)
DIS   144.67 (-1.69%)
Log in

Teligent Stock Price, Forecast & Analysis (NASDAQ:TLGT)

$0.63
-0.01 (-1.56 %)
(As of 11/15/2019 04:00 PM ET)
Today's Range
$0.62
Now: $0.63
$0.63
50-Day Range
$0.55
MA: $0.73
$0.99
52-Week Range
$0.42
Now: $0.63
$2.86
Volume700 shs
Average Volume181,655 shs
Market Capitalization$33.93 million
P/E RatioN/A
Dividend YieldN/A
Beta1.35
Teligent, Inc, a specialty generic pharmaceutical company, develops, manufactures, markets, and sells generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. It offers generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms. The company is also involved in contract manufacturing and development business, including the development, manufacturing, filling, and package of topical semi-solid and liquid products for branded and generic pharmaceutical customers, as well as for over-the-counter and cosmetic markets. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TLGT
CUSIPN/A
Phone856-697-1441

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$65.86 million
Book Value$0.34 per share

Profitability

Net Income$-36,260,000.00

Miscellaneous

Employees189
Market Cap$33.93 million
Next Earnings Date3/16/2020 (Estimated)
OptionableOptionable

Receive TLGT News and Ratings via Email

Sign-up to receive the latest news and ratings for TLGT and its competitors with MarketBeat's FREE daily newsletter.


Teligent (NASDAQ:TLGT) Frequently Asked Questions

What is Teligent's stock symbol?

Teligent trades on the NASDAQ under the ticker symbol "TLGT."

How were Teligent's earnings last quarter?

Teligent Inc (NASDAQ:TLGT) released its earnings results on Monday, November, 4th. The company reported ($0.04) earnings per share for the quarter, missing the consensus estimate of ($0.03) by $0.01. The business had revenue of $18.47 million for the quarter, compared to the consensus estimate of $19.82 million. Teligent had a negative return on equity of 173.43% and a negative net margin of 51.29%. View Teligent's Earnings History.

When is Teligent's next earnings date?

Teligent is scheduled to release their next quarterly earnings announcement on Monday, March 16th 2020. View Earnings Estimates for Teligent.

What price target have analysts set for TLGT?

2 Wall Street analysts have issued 1 year price objectives for Teligent's stock. Their forecasts range from $3.00 to $3.00. On average, they anticipate Teligent's stock price to reach $3.00 in the next twelve months. This suggests a possible upside of 376.2% from the stock's current price. View Analyst Price Targets for Teligent.

What is the consensus analysts' recommendation for Teligent?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teligent in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Teligent.

Has Teligent been receiving favorable news coverage?

Headlines about TLGT stock have trended somewhat negative recently, according to InfoTrie Sentiment Analysis. InfoTrie ranks the sentiment of news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Teligent earned a news impact score of -1.4 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Teligent.

Are investors shorting Teligent?

Teligent saw a decline in short interest in the month of September. As of September 30th, there was short interest totalling 8,070,000 shares, a decline of 6.4% from the August 30th total of 8,620,000 shares. Based on an average daily volume of 374,300 shares, the days-to-cover ratio is currently 21.6 days. Approximately 18.6% of the company's shares are short sold. View Teligent's Current Options Chain.

Who are some of Teligent's key competitors?

What other stocks do shareholders of Teligent own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teligent investors own include Novavax (NVAX), ChemoCentryx (CCXI), Aquinox Pharmaceuticals (AQXP), Voyager Therapeutics (VYGR), General Electric (GE), Bausch Health Companies (BHC), Ford Motor (F), Akorn (AKRX), Sangamo Therapeutics (SGMO) and TherapeuticsMD (TXMD).

Who are Teligent's key executives?

Teligent's management team includes the folowing people:
  • Mr. Jason Grenfell-Gardner M.B.A., M.B.A, Pres, CEO & Director (Age 44)
  • Mr. Stephen Richardson, Chief Scientific Officer (Age 53)
  • Mr. Martin Wilson, Gen. Counsel (Age 42)
  • Mr. Damian Finio, Corp. Sec. & CFO (Age 49)
  • Ms. Nadya Lawrence, Sr. VP of Technical Services (Age 50)

Who are Teligent's major shareholders?

Teligent's stock is owned by many different of institutional and retail investors. Top institutional investors include SG Americas Securities LLC (0.10%). Company insiders that own Teligent stock include Bhaskar Chaudhuri, Carole Ben-Maimon, Damian Finio, James C Gale, Jason Grenfell-Gardner and Stephen Richardson. View Institutional Ownership Trends for Teligent.

Which institutional investors are selling Teligent stock?

TLGT stock was sold by a variety of institutional investors in the last quarter, including SG Americas Securities LLC. View Insider Buying and Selling for Teligent.

How do I buy shares of Teligent?

Shares of TLGT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Teligent's stock price today?

One share of TLGT stock can currently be purchased for approximately $0.63.

How big of a company is Teligent?

Teligent has a market capitalization of $33.93 million and generates $65.86 million in revenue each year. The company earns $-36,260,000.00 in net income (profit) each year or ($0.33) on an earnings per share basis. Teligent employs 189 workers across the globe.View Additional Information About Teligent.

What is Teligent's official website?

The official website for Teligent is http://www.teligent.com/.

How can I contact Teligent?

Teligent's mailing address is 105 LINCOLN AVENUE, BUENA NJ, 08310. The company can be reached via phone at 856-697-1441 or via email at [email protected]


MarketBeat Community Rating for Teligent (NASDAQ TLGT)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  310 (Vote Outperform)
Underperform Votes:  236 (Vote Underperform)
Total Votes:  546
MarketBeat's community ratings are surveys of what our community members think about Teligent and other stocks. Vote "Outperform" if you believe TLGT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TLGT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/15/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel